

소개
PLEASE NOTE. THIS IS A BOOK. NOT THE ACTUAL MEDICATION. Ronapreve is a monoclonal antibody treatment to prevent and treat COVID-19 developed by Regeneron Pharmaceuticals and Roche Pharmaceuticals. The drug contains a pair of antibodies created in a laboratory, and has been shown to lower hospitalisation or mortality from COVID by 70%, as well as shortening the duration of symptoms by four days. It can be administered either through injection or infusion.



